Zenabis Announces Positive Operational Updates
Zenabis is pleased to announce that, further to the previously announced receipt of its Health Canada export license to the EU, it has made its initial shipment of approximately 47 kg of pharmaceutical-grade cannabis to its EU partner located in Malta. This initial shipment will be used to obtain EU GMP certification for its partner’s production line. Once certified, Zenabis expects to commence bulk shipments of pharmaceutical-grade cannabis to its partners with volumes eventually expected to ramp up to approximately 400 kg per month.
Additionally, Zenabis is pleased to announce that, subject to the Company receiving the requisite export permits, it has scheduled for its previously announced shipment of approximately 300 kg of pharmaceutical-grade cannabis to a customer in Israel for April 2020.